Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Novo Nordisk Farma Oy
OY
Active
Y-tunnus 0100873-3
Linnoitustie 6, 02600
Esbo
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1972
77 employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Novo Nordisk Farma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JT
Jaakko Tapio Linna
Chief Executive Officer
Chief Executive Officer
2018
Former (3)
MR
Merja Ritva Hannele Prihti
Audit
Audit
2018 – 2021
KP
Katja Pauliina Leppälahti
Audit
Audit
2021 – 2022
JV
Janne Vihtori Vikman
Audit
Audit
2022 – 2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
DM
David Marcus Svensson
Board of Directors
2026
JB
Jeppe Boller Theisen
Board of Directors
2025
JE
Jonas Emil Kongshøj Larsen
Chairperson
2024
Former (6)
MJ
Matt Joseph Regan
Chairperson
2018 – 2020
JW
Jesper Wenzel Larsen
Board of Directors
2018 – 2019
ME
Malin Eva Maria Arvling Andreasen
Board of Directors
2024 – 2026
TH
Tomas Haagen
Board of Directors
2018 – 2024
MV
Mads Veggerby Lausten
Board of Directors
2019 – 2025
FK
Frederik Kier
Chairperson
2020 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Novo Nordisk Farma Oy
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network